JezK

Edit File: 1598090777.M403790P2447905.mocha3025.mochahost.com,S=72929,W=74457:2,S

Envelope-to: ahf-finance@jack.ngo,
 ahmad@jack.ngo,
 finance.manager@jack.ngo,
 ghani@jack.ngo,
 hadi@jack.ngo,
 hafiz@jack.ngo,
 hamdard@jack.ngo,
 haseeb.shirzada@jack.ngo,
 musawy@jack.ngo,
 nooromari@jack.ngo,
 pharmacy.kdz@jack.ngo,
 pharmacy@jack.ngo,
 takal@jack.ngo
Delivery-date: Sat, 22 Aug 2020 06:06:17 -0400
From: <dr.safar@jack.ngo>
To: <ahmad@jack.ngo>
Cc: <finance.manager@jack.ngo>,
	<ahf-finance@jack.ngo>,
	<hadi@jack.ngo>,
	"'Shirzada'" <haseeb.shirzada@jack.ngo>,
	<hamdard@jack.ngo>,
	"'Nooromari'" <nooromari@jack.ngo>,
	<ahmad@jack.ngo>,
	"'Sardar Wali Takal'" <takal@jack.ngo>,
	"'hafiz'" <hafiz@jack.ngo>,
	<pharmacy.kdz@jack.ngo>,
	<pharmacy@jack.ngo>,
	<hafiz@jack.ngo>,
	<musawy@jack.ngo>,
	<ghani@jack.ngo>
References: <005a01d67701$8dde3130$a99a9390$@jack.ngo> <003401d677eb$0e7d4940$2b77dbc0$@jack.ngo> <000901d67860$d67cb960$83762c20$@jack.ngo>
In-Reply-To: <000901d67860$d67cb960$83762c20$@jack.ngo>
Subject: RE: Medicine of AHF
Date: Sat, 22 Aug 2020 14:34:17 +0430
Message-ID: <006601d6786b$9dbe3350$d93a99f0$@jack.ngo>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0067_01D67891.55B589C0"
Thread-Index: AQN+pP+2z87vNQPs/+H5nxjOnGzc4AIF8yeTAQB6Vcil21YQMA==
Content-Language: en-us

This is a multipart message in MIME format.

------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_0068_01D67891.55B589C0"

------=_NextPart_001_0068_01D67891.55B589C0
Content-Type: text/plain;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

Dear Dr Sahib Ahmad

=20

For your kind information, Dr Hafiz sent me a voice message on Wednesday =
(19th August 2020), Dr hafiz asked me about GRNs of the second =
installment of the medicine which was received on 29th of June 2020, I =
replied that I will find it on Mangal, but Hakim Mangal tried but =
couldn=E2=80=99t fine those GRNs and of course the serums were also not =
found, after that I wrote an email with the clarification to your email. =

The issue was bigger than a voice message so I didn=E2=80=99t reply to =
Dr Hafiz for the second time and I shared with whole management team.

=20

Once again I am saying we may have received some of the left outs form =
first quarter (19th June 2020), but Hakim Mangal has not provided me the =
GRNs, he says I don=E2=80=99t have it. And for the Serums, we =
don=E2=80=99t have received the serums in our Kunduz Warehouse/stock, =
Hakim mangal Claims.

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Reach WoAA survey =
Focal Point

Just for Afghan Capacity and Knowledge       =D8=A8=D9=84=D9=86=D8=AF =
=D8=A8=D8=B1=D8=AF=D9=86 =D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =
=D9=88 =D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9) =20

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: <mailto:Dr.Safar@jack.ngo> Dr.Safar@jack.ngo

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 Dr.Safar@yahoo.com

Website:www.jack.ngo

From: pharmacy@jack.ngo [mailto:pharmacy@jack.ngo]=20
Sent: Saturday, August 22, 2020 1:17 PM
To: pharmacy.kdz@jack.ngo; ghani@jack.ngo; 'musawy' <musawy@jack.ngo>
Cc: finance.manager@jack.ngo; ahf-finance@jack.ngo; hadi@jack.ngo; =
'Shirzada' <haseeb.shirzada@jack.ngo>; hamdard@jack.ngo; 'Nooromari' =
<nooromari@jack.ngo>; ahmad@jack.ngo; dr.safar@jack.ngo; 'Sardar Wali =
Takal' <takal@jack.ngo>; 'hafiz' <hafiz@jack.ngo>
Subject: RE: Medicine of AHF

=20

Dear Kunduz Colleagues,

Please always follow the reception procedure that you should not face =
any issue in future:

-        When a purchase order is raised, Kabul team will inform you for =
its details.

-        When items are physically arrived in Kunduz warehouse, you =
should assign a committee to check the items quantity and quality.

-        The committee to sign in GRN.

-        A scan copy of GRN to be sent to Kabul and original to be kept =
in your filling system.

-        GRN to be updated when some missing portion of original order =
arrived later.

=20

With best regards

JACK KBL Pharmacy Team

From: ahmad@jack.ngo <mailto:ahmad@jack.ngo> [mailto:ahmad@jack.ngo]=20
Sent: Friday, August 21, 2020 11:14 PM
To: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo> ; 'Sardar Wali Takal' <takal@jack.ngo =
<mailto:takal@jack.ngo> >; takal@jack.af <mailto:takal@jack.af> ; =
'hafiz' <hafiz@jack.ngo <mailto:hafiz@jack.ngo> >
Cc: pharmacy.kdz@jack.ngo <mailto:pharmacy.kdz@jack.ngo> ; =
pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; logistic.manager@jack.ngo =
<mailto:logistic.manager@jack.ngo> ; finance.manager@jack.ngo =
<mailto:finance.manager@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; hadi@jack.ngo <mailto:hadi@jack.ngo> ; =
'Shirzada' <haseeb.shirzada@jack.ngo <mailto:haseeb.shirzada@jack.ngo> =
>; hamdard@jack.ngo <mailto:hamdard@jack.ngo> ; 'Nooromari' =
<nooromari@jack.ngo <mailto:nooromari@jack.ngo> >
Subject: RE: Medicine of AHF

=20

Dear Safar Sahib,=20

=20

First let me to thank you for the follow up ,this very important issue; =
secondly pharmacy teams in provincial and main offices are responsible =
to answer us and give us the acceptable justification; and moreover the =
medicines which are mentioned below are must to be find.=20

=20

Dear Dr. Hafiz,=20

=20

Please refer to below issue and follow with provincial pharmacy team to =
provide us the justification and present the medicines otherwise it is =
fraud.=20

=20

Dear Takal Sahib,=20

=20

For your information; some medicines which are purchased here for trauma =
care project and the pharmacy department here in main office said that =
we supplied them to Kunduz and the supplier which the name is clearly =
written in below email said too, that the medicine are supplied ; but =
pharmacy assistant of trauma project is not aware and the medicines are =
not in stock , GRN is not existed and even there is no any documents; so =
this is a serious issue ; your follow up is also needed.=20

=20

With Best Regards,

=20

Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D MD,PGD (Leadership) PGD (NMD), PMP

Program Manager=20

Address: First Street of Karta-e-Chahar, Kabul Afghanistan=20

Behind AWCC Main Office, House # 08

Ph: +93 +93(0)748480909=20

Email: ahmad <mailto:ahmad@jack.ngo> @jack.ngo =20

Website:www.jack.ngo=20

=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D

This e-mail and any files transmitted with it may contain privileged or =
confidential information. It is solely for use by the individual for =
whom it is intended, even if addressed incorrectly. If you received this =
e-mail in error, please notify the sender; do not disclose copy, =
distribute, or take any action in reliance on the contents of this =
information; and delete it from your system. Any other use of this =
e-mail is prohibited. The views expressed herein are those of the author =
and do not necessarily reflect the views or policies of jack =
(Afghanistan). Electronic transmissions may be recorded and =
monitored.For Verification Please Read the Barcode Reader. =20

=09
	=09
=20

=20

P Every 3000 sheets of paper costs us a tree. Please don't print this =
e-mail unless you really need to

=20

From: dr.safar@jack.ngo <mailto:dr.safar@jack.ngo> =
[mailto:dr.safar@jack.ngo]=20
Sent: Thursday, August 20, 2020 7:22 PM
To: ahmad@jack.ngo <mailto:ahmad@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo>=20
Cc: pharmacy.kdz@jack.ngo <mailto:pharmacy.kdz@jack.ngo> ; =
pharmacy@jack.ngo <mailto:pharmacy@jack.ngo> ; logistic.manager@jack.ngo =
<mailto:logistic.manager@jack.ngo> ; finance.manager@jack.ngo =
<mailto:finance.manager@jack.ngo> ; ahf-finance@jack.ngo =
<mailto:ahf-finance@jack.ngo> ; hadi@jack.ngo <mailto:hadi@jack.ngo> ; =
'Shirzada' <haseeb.shirzada@jack.ngo <mailto:haseeb.shirzada@jack.ngo> =
>; takal@jack.ngo <mailto:takal@jack.ngo> ; hamdard@jack.ngo =
<mailto:hamdard@jack.ngo>=20
Subject: Medicine of AHF

=20

Dear Dr Sahib Ahmad

I hope my email finds you in good health

=20

I am writing this email for clarification, not for allegations.=20

=20

Today when I asked AHF Pharmacy assistant about the medicine not =
received, he was not sure that which one was received or which one was =
not received, after departure of Dr Jamal (Kunduz Warehouse officer), =
Hakim Mangal couldn=E2=80=99t provide us the GRNs of the medicine which =
were not received in 19th June but it is certain that maybe some items =
of not received medicine were received in the second time (29 June =
2020). Although Hakim Mangal is pharmacy assistant of AHF projects, he =
is not fully in the picture of medicine recevial for AHF Trauma project.

=20

When Hakim Mangal contacted with the Supplier, Naib Hamza, they claimed =
that they have even sent the Serum (100 box), they even have the =
confirmation paper.

=20

And also Dr Zulmay Hamdard is in the picture, I also asked him, he has =
no idea about the confirmation paper of Naib Hamza Company, but one =
thing is certain, that JACK PO Warehouse didn=E2=80=99t receive the =
serums.

=20

My request from Pharmacy Team is that kindly provide the GRNs of the =
medicine which were received second time (the left outs of first =
quarter). For better understanding please refer to below table. AHF =
Pharmacy Assistant Mr Hakim Mangal couldn=E2=80=99t provide.

=20

Name

Description

Unit

Quantity 1st Quarter (not received)

Cimetidine

Amp-200mg

Pcs

300

Ringer Lactate

Serum-1000 Ml

bags

2800

Gauze Compress

Non Sterile

Pcs

3750

Gloves

Sterile-Size 8

Pcs

750

Needle=20

Disposible-G19

Pcs

300

Tape

10cm

Pcs

120

=20

Thank you & Best Regards

=20

Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D MD/GP/Social Service Provider

Project Manager-AHF Project / NER PSEA Focal Point / Reach WoAA survey =
Focal Point

Address: Kunduz,Kocha Sinama,First Region

Beside Da Afghanistan Bank, House # 08

Ph: +93 787 047 554 - +93 744 990 143 - +93792 716 026 =E2=80=93 +93777 =
469 663 =E2=80=93 +93706 179 758

Official Email: Dr.Safar@jack.ngo <mailto:Dr.Safar@jack.ngo>=20

Personal Email: <mailto:Dr.Safar001@outlook.com> =
Dr.Safar001@outlook.com =E2=80=93 Dr.Safar@yahoo.com =
<mailto:Dr.Safar@yahoo.com>=20

Website:www.jack.ngo

=09
	=09

=20

------=_NextPart_001_0068_01D67891.55B589C0
Content-Type: text/html;
	charset="utf-8"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head><meta =
http-equiv=3DContent-Type content=3D"text/html; charset=3Dutf-8"><meta =
name=3DGenerator content=3D"Microsoft Word 15 (filtered medium)"><style></style></head><body lang=3DEN-US =
link=3D"#0563C1" vlink=3D"#954F72"><div class=3DWordSection1>Dear Dr Sahib =
Ahmad<o:p></o:p><o:p>&nbsp;</o:p>For your kind =
information, Dr Hafiz sent me a =
voice message on Wednesday (19th August 2020), Dr hafiz asked =
me about GRNs of the second installment of the medicine which was =
received on 29th of June 2020, I replied that I will find it =
on Mangal, but Hakim Mangal tried but couldn=E2=80=99t fine those GRNs =
and of course the serums were also not found, after that I wrote an =
email with the clarification to your email. <o:p></o:p>The issue was bigger =
than a voice message so I didn=E2=80=99t reply to Dr Hafiz for the =
second time and I shared with whole management =
team.<o:p></o:p><o:p>&nbsp;</o:p>Once again I am saying =
we may have received some of the left outs form first quarter =
(19th June 2020), but Hakim Mangal has not provided me the =
GRNs, he says I don=E2=80=99t have it. And for the Serums, we =
don=E2=80=99t have received the serums in our Kunduz Warehouse/stock, =
Hakim mangal Claims.<o:p></o:p><a =
name=3D"_MailEndCompose"><o:p>&nbsp;</o:p></a>Thank you &amp; Best =
Regards<o:p></o:p><img width=3D61 height=3D48 id=3D"_x0000_i1027" =
src=3D"cid:image001.jpg@01D67891.50C88D40" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Reach WoAA survey Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =
=E2=80=93 Dr.Safar@yahoo.com<o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
div><div style=3D'border:none;border-top:solid #E1E1E1 =
1.0pt;padding:3.0pt 0in 0in 0in'>From: =
pharmacy@jack.ngo [mailto:pharmacy@jack.ngo] Sent: Saturday, =
August 22, 2020 1:17 PM To: pharmacy.kdz@jack.ngo; =
ghani@jack.ngo; 'musawy' &lt;musawy@jack.ngo&gt; Cc: =
finance.manager@jack.ngo; ahf-finance@jack.ngo; hadi@jack.ngo; =
'Shirzada' &lt;haseeb.shirzada@jack.ngo&gt;; hamdard@jack.ngo; =
'Nooromari' &lt;nooromari@jack.ngo&gt;; ahmad@jack.ngo; =
dr.safar@jack.ngo; 'Sardar Wali Takal' &lt;takal@jack.ngo&gt;; 'hafiz' =
&lt;hafiz@jack.ngo&gt; Subject: RE: Medicine of =
AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Kunduz Colleagues,<o:p></o:p>Please always follow the =
reception procedure that you should not face any issue in =
future:<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When a purchase order is raised, Kabul team will =
inform you for its details.<o:p></o:p><![if !supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>When items are physically arrived in Kunduz =
warehouse, you should assign a committee to check the items quantity and =
quality.<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>The committee to sign in =
GRN.<o:p></o:p><![if =
!supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>A scan copy of GRN to be sent to Kabul and =
original to be kept in your filling system.<o:p></o:p><![if !supportLists]>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
<![endif]>GRN to be updated when some missing portion of =
original order arrived later.<o:p></o:p><o:p>&nbsp;</o:p>With best =
regards<o:p></o:p>JACK KBL Pharmacy =
Team<o:p></o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a> [<a =
href=3D"mailto:ahmad@jack.ngo">mailto:ahmad@jack.ngo</a>] =
 Sent: Friday, August 21, 2020 11:14 PM To: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>; 'Sardar Wali =
Takal' &lt;<a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>&gt;; <a =
href=3D"mailto:takal@jack.af">takal@jack.af</a>; 'hafiz' &lt;<a =
href=3D"mailto:hafiz@jack.ngo">hafiz@jack.ngo</a>&gt; Cc: <a =
href=3D"mailto:pharmacy.kdz@jack.ngo">pharmacy.kdz@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:logistic.manager@jack.ngo">logistic.manager@jack.ngo</a>; =
<a =
href=3D"mailto:finance.manager@jack.ngo">finance.manager@jack.ngo</a>; =
<a href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; 'Shirzada' &lt;<a =
href=3D"mailto:haseeb.shirzada@jack.ngo">haseeb.shirzada@jack.ngo</a>&gt;=
; <a href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a>; 'Nooromari' =
&lt;<a =
href=3D"mailto:nooromari@jack.ngo">nooromari@jack.ngo</a>&gt; Subje=
ct: RE: Medicine of AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Safar Sahib, <o:p></o:p><o:p>&nbsp;</o:p>First let me to thank =
you for the follow up ,this very important issue; secondly pharmacy =
teams in provincial and main offices are responsible to answer us and =
give us the acceptable justification; and moreover the medicines which =
are mentioned below are must to be find. <o:p></o:p><o:p>&nbsp;</o:p>Dear Dr. Hafiz, =
<o:p></o:p><o:p>&nbsp;</o:p>Please refer to below =
issue and follow with provincial pharmacy team to provide us the =
justification and present the medicines otherwise it is fraud. =
<o:p></o:p><o:p>&nbsp;</o:p>Dear Takal Sahib, =
<o:p></o:p><o:p>&nbsp;</o:p>For your information; =
some medicines which are purchased here for trauma care project and the =
pharmacy department here in main office said that we supplied them to =
Kunduz and the supplier which the name is clearly written in below email =
said too, that the medicine are supplied ; but pharmacy assistant of =
trauma project is not aware and the medicines are not in stock , GRN is =
not existed and even there is no any documents; so this is a serious =
issue ; your follow up is also needed. <o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>With Best =
Regards,<o:p></o:p><o:p>&nbsp;</o:p><img border=3D0 =
width=3D49 height=3D38 id=3D"_x0000_i1025" =
src=3D"cid:image003.jpg@01D67890.70B4F720" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr.Noor Ahmad =E2=80=9CAhmad=E2=80=9D =
MD,PGD (Leadership) PGD (NMD), =
PMP<o:p></o:p>Program Manager =
<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: First Street of Karta-e-Chahar, Kabul =
Afghanistan <o:p></o:p>Behind AWCC Main Office, House # =
08<o:p></o:p>Ph: +93 +93(0)748480909 =
<o:p></o:p>Email: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>&nbsp; <o:p></o:p>Website:www.jack.ngo <o:p></o:p>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <o:p></o:p><![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D2 =
height=3D442></td></tr><tr><td></td><td><img width=3D115 height=3D115 =
src=3D"cid:image006.jpg@01D67891.50C88D40" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_1"></td></tr></table><![endif]><o:p>&nbsp;</o:p></=
p><o:p>&nbsp;</o:p><o:p>&nbsp;</=
o:p><o:p>&nbsp;</=
o:p> P<s=
pan =
style=3D'font-size:7.5pt;font-family:"Arial",sans-serif;color:green'> =
Ever=
y 3000 sheets of paper costs us a tree. Please don't print this e-mail =
unless you really need to<o:p></o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p><div><div =
style=3D'border:none;border-top:solid #E1E1E1 1.0pt;padding:3.0pt 0in =
0in 0in'>From: <a =
href=3D"mailto:dr.safar@jack.ngo">dr.safar@jack.ngo</a> [<a =
href=3D"mailto:dr.safar@jack.ngo">mailto:dr.safar@jack.ngo</a>] =
 Sent: Thursday, August 20, 2020 7:22 PM To: <a =
href=3D"mailto:ahmad@jack.ngo">ahmad@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Cc: <a =
href=3D"mailto:pharmacy.kdz@jack.ngo">pharmacy.kdz@jack.ngo</a>; <a =
href=3D"mailto:pharmacy@jack.ngo">pharmacy@jack.ngo</a>; <a =
href=3D"mailto:logistic.manager@jack.ngo">logistic.manager@jack.ngo</a>; =
<a =
href=3D"mailto:finance.manager@jack.ngo">finance.manager@jack.ngo</a>; =
<a href=3D"mailto:ahf-finance@jack.ngo">ahf-finance@jack.ngo</a>; <a =
href=3D"mailto:hadi@jack.ngo">hadi@jack.ngo</a>; 'Shirzada' &lt;<a =
href=3D"mailto:haseeb.shirzada@jack.ngo">haseeb.shirzada@jack.ngo</a>&gt;=
; <a href=3D"mailto:takal@jack.ngo">takal@jack.ngo</a>; <a =
href=3D"mailto:hamdard@jack.ngo">hamdard@jack.ngo</a> Subject: =
Medicine of AHF<o:p></o:p></div></div><o:p>&nbsp;</o:p>Dear Dr =
Sahib Ahmad<o:p></o:p>I hope my email finds you =
in good health<o:p></o:p><o:p>&nbsp;</o:p>I am =
writing this email for clarification, not for allegations. =
<o:p></o:p><o:p>&nbsp;</o:p>Today when I asked AHF Pharmacy assistant about the =
medicine not received, he was not sure that which one was received or =
which one was not received, after departure of Dr Jamal (Kunduz =
Warehouse officer), Hakim Mangal couldn=E2=80=99t provide us the GRNs of =
the medicine which were not received in 19th June but it is =
certain that maybe some items of not received medicine were received in =
the second time (29 June 2020). Although Hakim Mangal is pharmacy =
assistant of AHF projects, he is not fully in the picture of medicine =
recevial for AHF Trauma project.<o:p></o:p><o:p>&nbsp;</o:p>When Hakim =
Mangal contacted with the Supplier, Naib Hamza, they claimed that they =
have even sent the Serum (100 box), they even have the confirmation =
paper.<o:p></o:p><o:p>&nbsp;</o:p>And also Dr Zulmay Hamdard is in the picture, I also =
asked him, he has no idea about the confirmation paper of Naib Hamza =
Company, but one thing is certain, that JACK PO Warehouse =
didn=E2=80=99t receive the serums.<o:p></o:p><o:p>&nbsp;</o:p>My =
request from Pharmacy Team is that kindly provide the GRNs of the =
medicine which were received second time (the left outs of first =
quarter). For better understanding please refer to below table. AHF =
Pharmacy Assistant Mr Hakim Mangal couldn=E2=80=99t =
provide.<o:p></o:p><o:p>&nbsp;</o:p><table class=3DMsoNormalTable =
border=3D0 cellspacing=3D0 cellpadding=3D0 =
style=3D'border-collapse:collapse'><tr><td width=3D130 valign=3Dtop =
style=3D'width:77.9pt;border:solid windowtext =
1.0pt;background:#D9D9D9;padding:0in 5.4pt 0in 5.4pt'>Name<o:p></o:p></td><td width=3D140 =
valign=3Dtop style=3D'width:83.8pt;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Description<o:p></o:p></td><td =
width=3D120 valign=3Dtop style=3D'width:1.0in;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Unit<o:p></o:p></td><td =
width=3D293 valign=3Dtop style=3D'width:175.5pt;border:solid windowtext =
1.0pt;border-left:none;background:#D9D9D9;padding:0in 5.4pt 0in =
5.4pt'>Quantity 1st Quarter (not =
received)<o:p></o:p></td></tr><tr><td width=3D130 valign=3Dtop =
style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Cimetidine<o:p></o:p></td><td width=3D140 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Amp-200mg<o:p></o:p></td><td width=3D120 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>300<o:p></o:p></td></tr><tr><td width=3D130 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Ringer Lactate<o:p></o:p></td><td =
width=3D140 valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Serum-1000 Ml<o:p></o:p></td><td =
width=3D120 valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>bags<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>2800<o:p></o:p></td></tr><tr><td =
width=3D130 valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Gauze Compress<o:p></o:p></td><td =
width=3D140 valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Non Sterile<o:p></o:p></td><td width=3D120 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>3750<o:p></o:p></td></tr><tr><td =
width=3D130 valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Gloves<o:p></o:p></td><td width=3D140 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Sterile-Size 8<o:p></o:p></td><td =
width=3D120 valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>750<o:p></o:p></td></tr><tr><td width=3D130 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Needle <o:p></o:p></td><td width=3D140 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Disposible-G19<o:p></o:p></td><td =
width=3D120 valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>300<o:p></o:p></td></tr><tr><td width=3D130 =
valign=3Dtop style=3D'width:77.9pt;border:solid windowtext =
1.0pt;border-top:none;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Tape<o:p></o:p></td><td width=3D140 =
valign=3Dtop =
style=3D'width:83.8pt;border-top:none;border-left:none;border-bottom:soli=
d windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>10cm<o:p></o:p></td><td width=3D120 =
valign=3Dtop =
style=3D'width:1.0in;border-top:none;border-left:none;border-bottom:solid=
 windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>Pcs<o:p></o:p></td><td width=3D293 =
valign=3Dtop =
style=3D'width:175.5pt;border-top:none;border-left:none;border-bottom:sol=
id windowtext 1.0pt;border-right:solid windowtext =
1.0pt;background:#DEEAF6;padding:0in 5.4pt 0in 5.4pt'>120<o:p></o:p></td></tr></table><o:p>&nbsp;</o:p><o:p>&nbsp;</o:p>Thank you &amp; Best =
Regards<o:p></o:p><img border=3D0 width=3D61 height=3D48 =
id=3D"Picture_x0020_21" src=3D"cid:image007.jpg@01D67890.70B4F720" =
alt=3D"cid:image003.jpg@01D4B669.F250F440"><=
o:p></o:p>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p>Dr-Mohammad Hashim =E2=80=9CSafar=E2=80=9D =
MD/GP/Social Service =
Provider<o:p></o:p>Project Manager-AHF Project / NER PSEA =
Focal Point / Reach WoAA survey Focal Point<o:p></o:p>Just for Afghan Capacity and =
Knowledge&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; =
&nbsp;=D8=A8=D9=84=D9=86=D8=AF =D8=A8=D8=B1=D8=AF=D9=86 =
=D8=B3=D8=B7=D8=AD =D8=AF=D8=A7=D9=86=D8=B4 =D9=88 =
=D8=AA=D9=88=D8=A7=D9=86=D9=85=D9=86=D8=AF=DB=8C =
=D8=A7=D9=81=D8=BA=D8=A7=D9=86=D9=87=D8=A7 (=D8=AC=DA=A9)&nbsp; =
<o:p></o:p>Address: Kunduz,Kocha Sinama,First =
Region<o:p></o:p>Beside Da Afghanistan Bank, House # =
08<o:p></o:p>Ph: +93 787 047 554 - +93 744 990 143 - =
+93792 716 026 =E2=80=93 +93777 469 663 =E2=80=93 +93706 179 =
758<o:p></o:p>Official Email: <a =
href=3D"mailto:Dr.Safar@jack.ngo">Dr.Safar@jack.ngo</a><o:p></o:p>=
Personal Email: <a =
href=3D"mailto:Dr.Safar001@outlook.com">Dr.Safar001@outlook.com</a> =E2=80=93 <a =
href=3D"mailto:Dr.Safar@yahoo.com">Dr.Safar@yahoo.com</a><s=
pan style=3D'font-size:9.0pt;font-family:"Segoe =
UI",sans-serif;color:#548DD4'><o:p></o:p>Website:www.jack.ngo<o:p></o:p><=
p class=3DMsoNormal>=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=3D=
<o:p></o:p>This e-mail and any files =
transmitted with it may contain privileged or confidential information. =
It is solely for use by the individual for whom it is intended, even if =
addressed incorrectly. If you received this e-mail in error, please =
notify the sender; do not disclose copy, distribute, or take any action =
in reliance on the contents of this information; and delete it from your =
system. Any other use of this e-mail is prohibited. The views expressed =
herein are those of the author and do not necessarily reflect the views =
or policies of jack (Afghanistan). Electronic transmissions may be =
recorded and monitored.For Verification Please Read =
the Barcode Reader.&nbsp; <![if !vml]><table cellpadding=3D0 cellspacing=3D0 =
align=3Dleft><tr><td width=3D2 =
height=3D749></td></tr><tr><td></td><td><img width=3D115 height=3D115 =
src=3D"cid:image008.jpg@01D67891.50C88D40" alt=3D"jack smart code" =
v:shapes=3D"Picture_x0020_2"></td></tr></table><![endif]><o:p></o:p><o:p>&nbsp;</o:p></div></body></html>
------=_NextPart_001_0068_01D67891.55B589C0--

------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/jpeg;
	name="image003.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image003.jpg@01D67890.70B4F720>
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------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/png;
	name="image004.png"
Content-Transfer-Encoding: base64
Content-ID: <image004.png@01D67890.70B4F720>

iVBORw0KGgoAAAANSUhEUgAAASIAAAEiAQAAAAB1xeIbAAAABGdBTUEAALGOfPtRkwAAAAlwSFlz
AAAOxAAADsQBlSsOGwAAABl0RVh0U29mdHdhcmUATWljcm9zb2Z0IE9mZmljZX/tNXEAAAEMSURB
VGje7dnBDYMwDIVhSwzASKzOSAxQySWOE1pooIcYqdWfA1LCd3uynVLRL9YsKBQKhfoLJb4GlWkZ
1oOlnEyoaGUbXVw5rS9QoSpFYu/mEpMHhrpNvWSFulvlfoS6UZVc8kC46l+ojup9IufAruY2qova
LQ/s4r6K6qNsDkt52Fbn8bFLCBWgRNJJBqOdPOSYECpEpVaUwZZVHQ2oSOWVYMNYS02oHmoIFaB8
LJemlO9FtURQgcpyWTciZxMZFaGsKW0TuXUTRYUqr4mPv8BQkcqnQuOrDypClcKonQl1n7I7kKl0
L2p+7UT1V7kf5RIZtfUPCypEWS5bOM2JjOqvzhcKhUKhfl49AcZAJK+rvDc4AAAAAElFTkSuQmCC

------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/jpeg;
	name="image007.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image007.jpg@01D67890.70B4F720>
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------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01D67891.50C88D40>

------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/jpeg;
	name="image006.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image006.jpg@01D67891.50C88D40>
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------=_NextPart_000_0067_01D67891.55B589C0
Content-Type: image/jpeg;
	name="image008.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image008.jpg@01D67891.50C88D40>
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------=_NextPart_000_0067_01D67891.55B589C0--